Clinical trial
A 48-Month, Multi-Centre, Observational Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
NCT04293523 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 48-Month, Multi-Centre, Observational Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
- Lead sponsor
- Swedish Orphan Biovitrum
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 30, 2020
- Completion date
- May 4, 2026
- Enrollment
- 427 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.